Across Europe , awareness surrounding copyright as a therapy for psychiatric conditions is surging. While historically viewed primarily as an anesthetic agent, its promise in treating depression , particularly chronic cases, is driving a significant change in clinical practice . Despite this, access remains complex and differs widely between member